Profile: Medis-El Ltd. develops advanced proprietary technologies to satisfy the demand for cleaner and more efficient energy. We develop highly advanced proprietary technologies in a number of key areas of market demand such as greater and longer-lasting power through proprietary fuel cell technology for portable electronic devices and improved cell based medical diagnostics & research systems.
The company has revenues of < USD 1 Million, has ~70 employees. NASDAQ:MDTL (SEC Filings)
1 Products/Services (Click for related suppliers)
|
• Microbiology Diagnostic Device (FDA Code: LIB / 866.2660) A microorganism differentiation and identification device is a device intended for medical purposes that consists of one or more components, such as differential culture media, biochemical reagents, and paper discs or paper strips impregnated with test reagents, that are usually contained in individual compartments and used to differentiate and identify selected microorganisms. The device aids in the diagnosis of disease. |